Intervention

CyPass Micro-Stent

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 6 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials6

Recruiting0

Common conditions5

Lead sponsors shown2

Clinical trials

6 shown

Additional Long-Term Follow-up for Subjects Implanted With a CyPass® Micro-StentNCT04629521 · 2020-12-21

COMPLETED

A Study to Assess Long-Term Safety of the CyPass Micro-Stent in Patients Completing the COMPASS TrialNCT02700984 · 2016-03-30

COMPLETED

Clinical Evaluation of Visco-Assisted CyPass® Micro-Stent Implantation in Patients With Open Angle GlaucomaNCT02448875 · 2013-06-21

COMPLETED

Study of CyPass Implantation In Patients With Open Angle Glaucoma Refractory to Single or Multi-agent Topical TherapyNCT01166659 · 2010-02-01

COMPLETED

CyPass Clinical Experience StudyNCT01097174 · 2009-12-01

COMPLETED

Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract SurgeryNCT01085357 · 2009-09-01

COMPLETED

Common conditions

Primary Open Angle Glaucoma (POAG)3 Cataract2 Open Angle Glaucoma1 Open Angle Glaucoma (OAG)1 Primary Open Angle Glaucoma1

Leading sponsors

Transcend Medical, Inc.4 Alcon Research2

Trial status mix

COMPLETED6

Phase mix

NA5

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.